Sensitivity analysis to investigate the impact of a missing covariate on survival analyses using cancer registry data

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Statistics in Medicine

• Publication date

  2009-05-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/sim.3557PMID 19235263PMCID PMC2741403
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Regression modeling strategies].

  2011cited by this paper
• Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

  2008cited by this paper
• Identifiability assumptions for missing covariate data in failure time regression models.

  2007cited by this paper
• Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.

  2007cited by this paper
• Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: Is It Still Imperative in the Era of Targeted Therapy?

  2007cited by this paper
• Sorafenib in advanced clear-cell renal-cell carcinoma.

  2007cited by this paper
• Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.

  2007cited by this paper
• Disparities in treatment and outcome for renal cell cancer among older black and white patients.

  2007cited by this paper
• Prognostic ability of simplified nuclear grading of renal cell carcinoma

  2007cited by this paper
• Survival associated with treatment vs observation of localized prostate cancer in elderly men.

  2006cited by this paper
• A phase 3, randomized, 3-arm study of temsirolimus (TEMSR) or interferon-alpha (IFN) or the combination of TEMSR + IFN in the treatment of first-line, poor-risk patients with advanced renal cell carcinoma (adv RCC).

  2006cited by this paper
• A comparison of multiple imputation and doubly robust estimation for analyses with missing data

  2006cited by this paper
• Treatment of patients with metastatic renal cell cancer

  2006cited by this paper
• Risk of fracture after androgen deprivation for prostate cancer.

  2005cited by this paper
• Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study.

  2004cited by this paper
• Non‐ignorable missing covariate data in survival analysis: a case‐study of an International Breast Cancer Study Group trial

  2004cited by this paper
• A sensitivity analysis for nonrandomly missing categorical data arising from a national health disability survey.

  2003cited by this paper
• Augmented Inverse Probability Weighted Estimator for Cox Missing Covariate Regression

  2001cited by this paper
• Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

  2001cited by this paper
• Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

  1999cited by this paper
• Adjusting for Nonignorable Drop-Out Using Semiparametric Nonresponse Models

  1999cited by this paper
• Semiparametric Regression for Repeated Outcomes With Nonignorable Nonresponse

  1998cited by this paper
• Analysis of Incomplete Multivariate Data

  1997influential reference
• Analysis of semiparametric regression models for repeated outcomes in the presence of missing data

  1995cited by this paper
• On robust estimation of the location parameter

  1980cited by this paper
• INFERENCE AND MISSING DATA

  1975cited by this paper

• Sharp Bounds of the Causal Effect Under MNAR Confounding

  2024cites this paper
• Bounds and Sensitivity Analysis of the Causal Effect Under Outcome-Independent MNAR Confounding

  2024cites this paper
• Osteonecrosis of the Jaw Caused by Denosumab in Treatment-Naïve and Pre-Treatment with Zoledronic Acid Groups: A Time-to-Onset Study Using the Japanese Adverse Drug Event Report (JADER) Database

  2022cites this paper
• Implications of missing data on reported breast cancer mortality

  2022cites this paper
• Missing data in the medical record for oncology patients: prevalence and association with outcomes

  2020cites this paper
• Prevalence of Missing Data in the National Cancer Database and Association With Overall Survival

  2020cites this paper
• Jim Crow and estrogen-receptor-negative breast cancer: US-born black and white non-Hispanic women, 1992–2012

  2016cites this paper
• Renal Cancer Patients with Unknown Ethnicity in Cancer Registry Data: Comparisons to Patients with Known Ethnicity.

  2015cites this paper
• Identifiability of subgroup causal effects in randomized experiments with nonignorable missing covariates

  2014cites this paper
• An index of local sensitivity to non-ignorability for parametric survival models with potential non-random missing covariate: an application to the SEER cancer registry data

  2012cites this paper
• Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram.

  2010cites this paper